期刊文献+

用免疫组化法对发疹型药疹皮损中ICAM—1和HLA—DR及LFA—1的检测 被引量:2

Detection of Expressed Intercellular Adhesion Molecule - 1 and HLA- DR and Lymphocyte Function Association Antigen - 1 in Lesions of Exanthematous Drug Eruption by Immunohistochemistry
下载PDF
导出
摘要 目的探讨细胞间粘附分子-1(ICAM-1)和人类白细胞表面抗原-DR(HLA—DR)及淋巴细胞功能相关抗原-1(LFW—1)在发疹型药疹发病机制中的作用。方法用免疫组化LSAB法对34例发疹型药疹患者皮损组织和8例对照皮肤中ICAM-1和HLA-DR及LFW-1进行了检测。结果发现皮损中角质形成细胞表达ICAM—1和HLA-DR,其阳性率明显高于8例正常对照,在真皮的血管内皮细胞也有ICAM—1的表达,真皮浸润淋巴细胞还表达LFA-1。结论HLA-DR、ICAM-1和LFA-1参与了发疹型药疹的炎症过程。 Objective To explore the mechanism of HLA - DR, ICAM -1 and LFA - 1 in exanthematous drug eruption (EDE). Mathods The deposits of HLA - DR, ICAM - 1 and LFA - 1 were detected in biopsy specimens from acute lesions of 34 patients with EDE and 8 controls by LSAB of immunohistochemistry. Results It demonstrated that keratinocytes expression HLA - DR was stronger in EDE than that in control. Keratinocytes and endotheliocytes in blood vessel expressed ICAM - 1 and the perivascularly infiltrating lymphocytes expressed LFA - 1 in dermis. Conclusions These suggested that the expression of HLA - DR, ICAM - 1 and LFA- 1 could related with inflammation of EDE.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2000年第6期378-380,共3页 The Chinese Journal of Dermatovenereology
关键词 发疹型药疹 免疫组化 粘附分子-1 HLA-DR Exanthematous drug eruption(EDE) Immunohistochemistry ICAM-1 HLA-DR LFA-1|
  • 相关文献

参考文献1

二级参考文献2

  • 1阎伯龄,药疹与发疹性疾病的鉴别诊断,1991年
  • 2毕志刚,临床皮肤科杂志,1984年,13卷,1页

共引文献4

同被引文献17

  • 1钱丽旗,裴晓华,陈荣明,许芝银.利乳康口服液对乳腺增生大鼠血清性激素的影响[J].中国中医药信息杂志,2004,11(8):684-686. 被引量:15
  • 2钱丽旗,潘超,冯振卿,冷静,许芝银.利乳康液对乳腺增生模型乳腺、子宫及卵巢形态学的影响[J].南京中医药大学学报,2005,21(4):255-257. 被引量:11
  • 3陈允硕,何银华,高蓉,巫向前.乳腺肿瘤细胞图像分析与免疫细胞化学技术的研究[J].上海医学,1997,20(2):79-81. 被引量:3
  • 4Coarlson JA, Grabowski R, Chichester Piect Comparativeim - munophenolypic study of lichen sclerosus: epidemao tropriccd57 + lymphocytes are numerous - implicationsfor pathogenesisJ. Am J Dermatopathol,2000, Feb,220 ;7 - 16.
  • 5Chan, I, Oyama, N, Neill, SM, et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen selerosus. Clin Exp Dermatol 2004; 29:499.
  • 6Oyama, N,Chan, I, Neill, SM, etal. Development of antigen - specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 2004; 113:1550.
  • 7Purcell KG, Spencer LN, Simpson PM, et al.. HLA antigen in lichen sclenusos et atrophicus [ J ]. Arch Dermatol, 1990,126 ( 8 ) : 1043 - 10.
  • 8Scrimin, F, Rustja, S, Radillo, O, et al. Vulvar lichen sclerosus : An immunologic study. Obstet Gynecol 2000; 95:147.
  • 9Zur HH, Molecular pathogenisis of the cervix and itscausation by specific humam papillomavims types[ J ]. Cur topics Mirobiol and Immunol. 1994. 186:131 -156.
  • 10Ligumsky M,Simon PL, Karmeli F, et al. Role of in - lerleukin 1 in inflammatory bowel disease - enhanced pro - duction during aclive disease[J]. Gut,1990,31 (6) :686 -689.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部